Search Results: PARP inhibitor

• Health & Medicine

Study opens door to targeted treatments for oesophageal cancer

Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments. Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments.

5 September 2016

• Health & Medicine
• Science & Technology

All women with ovarian cancer should be offered genetic testing – so why aren’t they?

Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren't. We explore why. Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren't. We explore why.

17 August 2016

• Health & Medicine
• Science & Technology

Dundee research explains drug resistance in ovarian cancer

Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments. Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments.

10 August 2016

• For Researchers

A celebrated career in DNA repair: Tomas Lindahl

We look at how Tomas Lindahl’s discoveries have profoundly changed our understanding of cell response to cytotoxic therapies and the implications of this. We look at how Tomas Lindahl’s discoveries have profoundly changed our understanding of cell response to cytotoxic therapies and the implications of this.

10 August 2016

• Science & Technology
• Health & Medicine

Inherited gene faults could play greater role in advanced prostate cancer than previously thought

Inherited gene faults are more common among men with advanced prostate cancer than in those with localised disease. Inherited gene faults are more common among men with advanced prostate cancer than in those with localised disease.

7 July 2016

"Surprised and deeply honoured" - our chief executive receives a knighthood

Our chief executive, Harpal Kumar, has received a knighthood for services to cancer research Our chief executive, Harpal Kumar, has received a knighthood for services to cancer research

30 December 2015

• Health & Medicine

Ovarian cancer drug wins NICE approval

NICE has given the NHS the green light over a drug which can extend the lives of ovarian cancer patients. NICE has given the NHS the green light over a drug which can extend the lives of ovarian cancer patients.

11 December 2015

• Health & Medicine

Men with advanced prostate cancer could benefit from ‘targeted’ drug

A small UK clinical trial has found that a drug developed to target inherited gene faults could benefit some men whose prostate cancer has spread. A small UK clinical trial has found that a drug developed to target inherited gene faults could benefit some men whose prostate cancer has spread.

28 October 2015

• Science & Technology

4 ways that Tomas Lindahl’s Nobel Prize for Chemistry revolutionised cancer research

We explore the impact that Tomas Lindahl's Nobel Prize-winning research into how cells repair their DNA has helped cancer research. We explore the impact that Tomas Lindahl's Nobel Prize-winning research into how cells repair their DNA has helped cancer research.

7 October 2015

• Science & Technology
• Policy & Insight

Expert Opinion - treating cancer by exploiting how its DNA is repaired

We spoke to two of our own experts about how they're targeting fundamental repair processes in our cells to tip cancer cells over the edge. We spoke to two of our own experts about how they're targeting fundamental repair processes in our cells to tip cancer cells over the edge.

18 September 2015

• Science & Technology

Newcastle gets £5 million to boost drug development

Cancer Research UK’s Drug Discovery Committee has awarded the Northern Institute of Cancer Research £5M to bring more cancer drugs to clinic trials. Cancer Research UK’s Drug Discovery Committee has awarded the Northern Institute of Cancer Research £5M to bring more cancer drugs to clinic trials.

7 August 2015

• Science & Technology

Scientists solve breast and ovarian cancer genetic mystery

Francis Crick Institute scientists have solved a decades-old mystery and helped to unravel the genetic cause of some breast and ovarian cancers Francis Crick Institute scientists have solved a decades-old mystery and helped to unravel the genetic cause of some breast and ovarian cancers

16 July 2015